Novartis Option Funds to invest in enzyme-slaying
- Publisher
- Elsevier Science
- Year
- 2010
- Weight
- 61 KB
- Volume
- 2010
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
All of Nippon Shokubai's catalystresearch facilities are to be consolidated on 1 Apr 2010 to form its GSC Catalyst Technology Research Center. The move is designed to speed up the exchange of expertise and technologies in the areas of chemical-process catalysts, biotechnology-related catalysts, and fuel-cell materials among its scientists. GSC, which stands for green sustainable energy, will bring under one roof existing catalyst-related technologies, including pollution-control catalysts and process catalysts being studied at its research units in Himeji and Kawasaki, and biocatalysts and new energy-associated technologies being advanced in Suita, Tsukuba, and Himeji, all in Japan. The new centre will have around 100 employees, or roughly 25% of the firm's R&D workforce.
๐ SIMILAR VOLUMES
Investing can be one of the most reliable passports to a better life. But where should you invest your money'Mark Dampier has been helping thousands of investors answer this question for over 30 years. In his first ever book he brings together everything he has learnt from grilling fund managers, we
This paper discusses the investments needed for the introduction of hydrogen as a transport fuel. Using option theory, we develop a model to calculate the value and optimal timing of a first commercial rollout of hydrogen vehicles in a larger area, taking Japan as a specific example. We find that th
This study focuses on how to assess the optimal environmental investment decisions under economic and ecological uncertainty, and establishes the continuous time model using the real option approach to optimize environmental pollution policy. Unlike traditional cost benefit analysis, this work exten